Yes this has the potential to be a company maker for PIQ. The importance of this is being missed by the market.
It is disappointing to see where the SP has got to, but quality and long term potential is often not of interest to the average biotech investor who are looking for the next hype train. Might be time to buy.
- Forums
- ASX - By Stock
- PIQ
- Ann: Appendix 4C - March 2019 Quarterly Report
PIQ
proteomics international laboratories ltd
Add to My Watchlist
4.92%
!
29.0¢

Ann: Appendix 4C - March 2019 Quarterly Report, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
-0.015(4.92%) |
Mkt cap ! $47.42M |
Open | High | Low | Value | Volume |
30.0¢ | 31.0¢ | 28.5¢ | $191.2K | 643.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 53694 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 51000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 53694 | 0.295 |
5 | 47282 | 0.280 |
3 | 141892 | 0.275 |
1 | 25000 | 0.270 |
1 | 10000 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 51000 | 2 |
0.330 | 2000 | 1 |
0.345 | 1260 | 1 |
0.350 | 50000 | 1 |
0.355 | 2498 | 1 |
Last trade - 15.36pm 26/06/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online